These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7559264)

  • 21. A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma.
    Razzouk H; dos Santos L; Giudicelli J; Queirós M; de Lurdes Chieira M; Castro A; Ramos C; Lindbladh C
    Int J Pharm; 1999 Apr; 180(2):169-75. PubMed ID: 10370187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis.
    Storms WW; Pearlman DS; Chervinsky P; Grossman J; Halverson PC; Freitag JJ; Widlitz MD
    Ear Nose Throat J; 1994 Jun; 73(6):382-6, 390-4. PubMed ID: 8076537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I; Williams M; Power S; Pilcher J; Weatherall M; Baines A; Moynihan J; Kempsford R; Beasley R;
    Respir Med; 2016 Oct; 119():115-121. PubMed ID: 27692131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model.
    Weiler JM; Meltzer EO; Benson PM; Weiler K; Widlitz MD; Freitag J
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):972-80. PubMed ID: 7798545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of azelastine on allergen- and exercise-induced asthma.
    Motojima S; Ohashi Y; Otsuka T; Fukuda T; Makino S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):174-8. PubMed ID: 3907651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
    Rafferty P; Harrison PJ; Aurich R; Holgate ST
    J Allergy Clin Immunol; 1988 Dec; 82(6):1113-8. PubMed ID: 2904931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group.
    Schwartz HJ; Petty T; Dubé LM; Swanson LJ; Lancaster JF
    Arch Intern Med; 1998 Jan; 158(2):141-8. PubMed ID: 9448552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effect of azelastine hydrochloride on histamine- and allergen-induced bronchoconstriction in atopic asthma.
    Rafferty P; Holgate ST
    Clin Exp Allergy; 1989 May; 19(3):315-20. PubMed ID: 2736431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
    Singh D; Pujol H; Ribera A; Seoane B; Massana E; Astbury C; Ruiz S; de Miquel G
    BMC Pulm Med; 2014 Nov; 14():176. PubMed ID: 25398689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study.
    Giede-Tuch C; Westhoff M; Zarth A
    Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
    Ringdal N; Derom E; Wåhlin-Boll E; Pauwels R
    Respir Med; 1998 Aug; 92(8):1017-21. PubMed ID: 9893769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ferguson GT; FitzGerald JM; Bleecker ER; Laviolette M; Bernstein D; LaForce C; Mansfield L; Barker P; Wu Y; Jison M; Goldman M;
    Lancet Respir Med; 2017 Jul; 5(7):568-576. PubMed ID: 28545978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis.
    Newson-Smith G; Powell M; Baehre M; Garnham SP; MacMahon MT
    Eur Arch Otorhinolaryngol; 1997; 254(5):236-41. PubMed ID: 9195148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of azelastine on the seasonal increase in non-specific bronchial responsiveness to methacholine in pollen allergic patients. A randomized, double-blind placebo-controlled, crossover study.
    Balzano G; Gallo C; Masi C; Cocco G; Ferranti P; Melillo E; Seccia G
    Clin Exp Allergy; 1992 Mar; 22(3):371-7. PubMed ID: 1350232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.